
Lundbeck has announced that its alcohol pill, Selincro, will be available on the Danish market from today. The launch follows a recent decision from the Danish Health and Medicines Authority not to grant general reimbursement for the drug. According to Lundbeck, that decision came as no surprise and will not impact future sales of the product – and the group is pleased with the Danish launch.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app